department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

hydrogen peroxide · pharmadog

pharmadog
drugs
hydrogen peroxide

drug

patient view →

hydrogen peroxide

Marketedupdated 2mo ago

by Kortuc Japan LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

hydrogen peroxide [USP]

indication

Cervical Cancer

phase

marketed

🐶 often sniffed alongside

top 4

tagInfectious Disease1 co-mentions · 1 sources
tagAdCom1 co-mentions · 1 sources
tag510(k) Clearance1 co-mentions · 1 sources
tagRecall1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 57m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 21, 2035

~8.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

Jul 4, 2035formulationUS 9675639
Apr 21, 2035formulationUS 10098910
Apr 21, 2035formulationUS 10493103
Apr 21, 2035formulationUS 10729720
Apr 21, 2035method-of-use (U-2205)US 9980983

Trials studying hydrogen peroxide

phase2KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancerrecruitingn=184
N/AClinical Evaluation of Enamel Microhardness Using Tooth Whitening Agentscompletedn=40
N/APost-incision Antimicrobial Wash vs C. Acnes in Shoulder Arthroplastyrecruitingn=150
N/AClinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lenscompletedn=18
N/AAssessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lensescompletedn=16
EP1Efficacy of Hydrogen Peroxide Gel on Periodontitis With Diabeteswithdrawn
N/AEfficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Salivacompletedn=54